Table 1.
Men | Women (Nonpregnant) | P | |
---|---|---|---|
n | 18,686 | 10,243 | |
Age, yr | 54 (44–65) | 56 (45–66) | <0.0001 |
Smoking, n (%) | 2,068 (11.16) | 441 (4.33) | <0.0001 |
Mortality, n (%) | 5,419 (29.00) | 2,631 (25.69) | <0.0001 |
ICU, n (%) | 1,948 (10.44) | 875 (8.55) | <0.0001 |
Intubation, n (%) | 2,021 (10.83) | 876 (8.56) | <0.0001 |
Pneumonia, n (%) | 12,600 (67.43) | 6,713 (65.54) | 0.0011 |
CVD, n (%) | 728 (3.93) | 477 (4.69) | 0.0023 |
Hypertension, n (%) | 5,611 (30.29) | 3,960 (38.91) | <0.0001 |
Diabetes, n (%) | 5,246 (28.32) | 3,561 (35.01) | <0.0001 |
Obesity, n (%) | 4,067 (22.01) | 2,908 (28.63) | <0.0001 |
Asthma, n (%) | 321 (1.73) | 366 (3.60) | <0.0001 |
COPD, n (%) | 604 (3.26) | 498 (4.89) | <0.0001 |
Immunosuppression, n (%) | 406 (2.19) | 339 (3.33) | <0.0001 |
CKD, n (%) | 828 (4.47) | 534 (5.25) | 0.0031 |
Indigenous population, n (%) | 321 (1.72) | 164 (1.60) | 0.472 |
COVID-19, coronavirus disease 2019; ICU, intensive care unit; COPD, chronic obstructive pulmonary disorder; CKD, chronic kidney disorder; CVD, cardiovascular disorder. n, number of subjects. χ2 test for categorical variables and Student’s t test for continuous variable were used.